PR Newswire Clinical TrialsOriginal article
Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026
ConferenceNeutral
AI Analysis
Summary
Immunic announced a virtual R&D day focused on relapsing multiple sclerosis scheduled for September 9, 2026. The company is a late-stage biotech developing novel oral therapies for neurologic diseases.
Importance:3/10
Sentiment:
0.00
Multiple sclerosisOral therapiesNeurologic diseasesR&D dayVirtual event
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on September 2, 2026 10:30 AM